Corient Private Wealth’s Penumbra PEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$555K Buy
1,757
+253
+17% +$82K ﹤0.01% 2154
2026
Q1
$493K Buy
1,504
+75
+5% +$25.4K ﹤0.01% 2040
2025
Q4
$444K Sell
1,429
-1,145
-44% -$316K ﹤0.01% 1929
2025
Q3
$652K Buy
2,574
+239
+10% +$60.3K ﹤0.01% 1651
2025
Q2
$599K Buy
2,335
+92
+4% +$25K ﹤0.01% 1605
2025
Q1
$600K Buy
2,243
+548
+32% +$148K ﹤0.01% 1512
2024
Q4
$403K Buy
1,695
+61
+4% +$13.9K ﹤0.01% 1729
2024
Q3
$318K Sell
1,634
-1,228
-43% -$232K ﹤0.01% 1988
2024
Q2
$515K Buy
2,862
+1
+0% +$200 ﹤0.01% 1623
2024
Q1
$639K Sell
2,861
-854
-23% -$211K ﹤0.01% 1505
2023
Q4
$934K Buy
3,715
+1,249
+51% +$276K ﹤0.01% 1314
2023
Q3
$597K Sell
2,466
-8,940
-78% -$2.48M ﹤0.01% 1391
2023
Q2
$3.92M Buy
11,406
+192
+2% +$59K 0.01% 705
2023
Q1
$3.13M Buy
11,214
+1,822
+19% +$465K 0.01% 714
2022
Q4
$2.09M Buy
+9,392
New +$1.84M 0.01% 692

Other funds holding PEN

Corient Private Wealth's PEN Position: Q2 2026 in Review

Corient Private Wealth increased its Penumbra (PEN) stake by 17% in Q2 2026, buying an estimated $82K and bringing the position to 1,757 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #2154.

Corient Private Wealth first reported a position in PEN in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.92M in Q2 2023. 451 funds tracked by Wall St. Rank hold PEN as of Q2 2026.

  • Corient Private Wealth held 1,757 shares of Penumbra worth $555K as of Q2 2026.
  • Corient Private Wealth bought 253 Penumbra shares in Q2 2026, an estimated $82K.
  • Penumbra made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2154 holding.
  • Corient Private Wealth first reported a position in Penumbra in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Penumbra position peaked at $3.92M in Q2 2023.
  • 451 funds tracked by Wall St. Rank held Penumbra as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.